Evidence map›Paper›PMID 33952556›Full record

ArticleBMJ open2021

Clinical outcomes associated with prostate cancer conspicuity on biparametric and multiparametric MRI: a protocol for a systematic review and meta-analysis of biochemical recurrence following radical prostatectomy.

Naomi Morka, Benjamin S Simpson, Rhys Ball, Alex Freeman, Alex Kirkham, Daniel Kelly, Hayley C Whitaker, Mark Emberton, Joseph M Norris

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Association between Pre-Operative Total Prostate-Specific Antigen and Survivorship of Prostate Cancer following Radical Prostatectomy: A Systematic Review.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2024
    Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Naomi MorkaUniversity College London Medical School, London, UK.ORCID 0000-0002-1925-7223
Benjamin S SimpsonUCL Division of Surgery & Interventional Science, University College London, London, UK.ORCID 0000-0003-3685-6110
Rhys BallDepartment of Pathology, University College London Hospitals NHS Foundation Trust, London, London, UK.
Alex FreemanDepartment of Pathology, University College London Hospitals NHS Foundation Trust, London, London, UK.
Alex KirkhamDepartment of Radiology, University College London Hospitals NHS Foundation Trust, London, UK.
Daniel KellySchool of Healthcare Sciences, College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK.ORCID 0000-0002-1847-0655
Hayley C WhitakerUCL Division of Surgery & Interventional Science, University College London, London, UK.
Mark EmbertonUCL Division of Surgery & Interventional Science, University College London, London, UK.
Joseph M NorrisUCL Division of Surgery & Interventional Science, University College London, London, UK joseph.norris@ucl.ac.uk.ORCID 0000-0003-2294-0303
University College London · GBUniversity College London Hospitals NHS Foundation Trust · GBUniversity College Hospital · GBCardiff University · GB

Funding

Medical Research Council MR/S00680X/1
6 · The paper itself

Abstract

introductionThere is an increasing body of evidence to suggest that visibility of prostate cancer on magnetic resonance (MRI) may be related to likelihood of adverse pathological outcomes. Biochemical recurrence (BCR) after radical prostatectomy remains a significant clinical challenge and a means of predicting likelihood of this prior to surgery could inform treatment choice. It appears that MRI could be a potential candidate strategy for BCR prediction, and as such, there is a need to review extant literature on the prognostic capability of MRI. Here, we describe a protocol for a systematic review and meta-analysis of the utility of biparametric MRI (bpMRI) and multiparametric MRI (mpMRI) in predicting BCR following radical prostatectomy for prostate cancer treatment. METHODS AND ANALYSIS: PubMed, MEDLINE, Embase and Cochrane databases will be searched and screening will be guided by the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. In order to meet the inclusion criteria, papers must be English-language articles involving patients who have had bpMRI or mpMRI for suspected prostate cancer and have undergone radical prostatectomy as definitive therapy. Patients must have had prostate-specific antigen monitoring before and after surgery. All relevant papers published from July 1977 to October 2020 will be eligible for inclusion. The Newcastle-Ottawa score will be used to determine the quality and bias of the studies. This protocol is written in-line with the PRISMA protocol 2015 checklist. ETHICS AND DISSEMINATION: There are no relevant ethical concerns. Dissemination of this protocol will be via peer-reviewed journals as well as national and international conferences. PROSPERO REGISTRATION NUMBER: CRD42020206074.

Indexed as

Multiparametric Magnetic Resonance ImagingProstatic NeoplasmsHumansMagnetic Resonance ImagingMaleMeta-Analysis as TopicProstatectomymagnetic resonance imagingprostate diseaseurological tumoursurology

Identifiers

PMID33952556
PMCPMC8103365
OpenAlexW3159603438

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.